“I mean Q3 tends to be the lightest. So you'd expect it to come down in the second quarter. Q3 will be a lot lighter.”

In context

“r this quarter. Remember, as Michel alluded in his remarks, that seasonality was kind of masked in the last few years with COVID and different behaviors on the dental side and clearly on the mortality side in terms of what we've seen. And that's just now returning to a more regular pattern, if you will. So I hope that helps you think through the guidance growth, both given the top line number that I've articulated as well as the midpoint of these ratios for the full year? Thomas Gallagher: That does. And if I could just sneak in one other follow-up. So dental utilization, you would fully expect that to be far lower in 2Q than 1Q? Or is there going to be some tail on that where you might see some level of higher utilization and lower earnings into 2Q as well, would you say? Ramy Tadros: I mean Q3 tends to be the lightest. So you'd expect it to come down in the second quarter. Q3 will be a lot lighter. So there's going to be always -- there will be a decrease, whether it's going to happen as a sharp cliff in Q2 and then another one in Q3 or different pattern, it's hard to predict. But again, think of it as a full year range and think of that ratio coming to the midpoint for the full year. John McCallion: And Tom, maybe I'll just add a follow-up again on your first question. I mean, I think also just you only focused on XVII. But as I said, I think what's really important is that we think of the all-in spread here, and that's -- all of that is very much in line with what we gave in the outlook for the midpoint of the range. Operator: Next, we move on to Brian Meredith with UBS. Justin Tucker: This is Justin Tucker on for Brian. My first question is about RIS. When looking at the struc”